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tions were noted in 2 patients and hardware problems (elec-
trode dislocation and breakage of the extension cable) in 1 
patient.  Conclusion: Our data showed Gpi-DBS to offer a 
very effective and safe therapy for different kinds of primary 
dystonia, with a significant long-term benefit in the majority 
of cases.  Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 In most cases, primary dystonia with its different phe-
notypes is a severely disabling disease. Etiologically, a 
pathological process within the basal ganglia is supposed 
to be responsible for decreased motor cortex inhibition. 
Affected patients suffer from repetitive twisting move-
ments or abnormal postures due to involuntary muscle 
contractions  [1, 2] . While conservative (medical) treat-
ment options are extremely limited for generalized dys-
tonia, in segmental dystonia, injections of botulinum 
toxin can alleviate symptoms for extended periods, but 
can also fail after repeated application  [3, 4] .
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 Abstract 
 Background: Deep brain stimulation (DBS) of the globus 
pallidus internus (GPi) offers a very promising therapy for 
medically intractable dystonia. However, little is known 
about the long-term benefit and safety of this procedure. 
We therefore performed a retrospective long-term analysis 
of 18 patients (age 12–78 years) suffering from primary gen-
eralized (9), segmental (6) or focal (3) dystonia (minimum fol-
low-up: 36 months).  Methods: Outcome was assessed using 
the Burke-Fahn-Marsden (BFM) scores (generalized dysto-
nia) and the Tsui score (focal/segmental dystonia). Follow-up 
ranged between 37 and 90 months (mean 60 months).  Re-
sults: Patients with generalized dystonia showed a mean im-
provement in the BFM movement score of 39.4% (range 0–
68.8%), 42.5% (range –16.0 to 81.3%) and 46.8% (range –2.7 
to 83.1%) at the 3- and 12-month, and long-term follow-up, 
respectively. In focal/segmental dystonia, the mean reduc-
tion in the Tsui score was 36.8% (range 0–100%), 65.1% (range 
16.7–100%) and 59.8% (range 16.7–100%) at the 3- and 12-
month, and long-term follow-up, respectively. Local infec-
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 For many years, stereotactic operations have been an 
alternative for patients with medically intractable dysto-
nia. In the past, surgical treatment consisted mainly of 
stereotactically guided localized tissue destruction (e.g. 
thermocoagulation) inside thalamic motor nuclei or in-
side the globus pallidus internus (GPi). Although the mo-
tor symptoms improved following lesioning, there is also 
a considerable risk of adverse events and, moreover, the 
initial improvement can decrease over time  [5–7] . In con-
trast to ablative stereotactic surgery, chronic stimulation 
can be safely used bilaterally. In addition, most stimula-
tion-induced side effects and/or a decrease in the clinical 
benefit can be corrected by readjustment of stimulation 
parameters. During the last years, several study groups 
presented data on rather small patient cohorts using the 
GPi as target for deep brain stimulation (DBS)  [8–11] . 
Only six recently published reports of larger series cov-
ered  1 15 patients  [12–17] . Based on convincing solid data 
from the prospective controlled studies by Vidailhet et al. 
 [16, 17] along with the results of the prospective random-
ized controlled two-arm study by Kupsch et al.  [18] , which 
showed the efficacy of bilateral GPi stimulation in com-
parison to sham stimulation in 40 patients with primary 
dystonia, evidence of the effectiveness of GPi-DBS in dys-
tonia was accumulating. However, the mean follow-up of 
the cited studies was 22.3 months. Therefore, apart from 
the 3-year results from the controlled prospective series 
by Vidailhet et al.  [17] or the very recently published data 
from a small case series (only 7 patients with primary 
dystonia) by Loher  [19] , little is known about the long-
term efficacy and safety of chronic GPi stimulation in 
different types of dystonia or about pretreatment factors 
possibly predicting clinical outcome. To be able to ad-
dress these problems in the present analysis, we pooled 
the immediate postoperative results and long-term fol-
low-up data from two stereotactic centers analyzing 18 
patients suffering from different types of primary dysto-
nia with special focus on long-term efficacy and safety.
 Patients and Methods 
 Patient Population/Inclusion Criteria 
 Patients with a history of severely disabling, medically intrac-
table primary dystonia and a follow-up of  6 36 months after im-
plantation of GPi electrodes were considered eligible for the pres-
ent analysis. Finally, a cohort of 18 (Munich: 12, Cologne: 6) con-
secutive patients (12 females, 6 males; mean age: 42.3 years, range 
12–78 years) suffering from primary generalized (9), segmental 
(6) and focal (3) dystonia treated with GPi-DBS between February 
1999 and February 2002 were included. The reference point of this 
study was the date of implantation. All patients who suffered from 
cervical dystonia had initially been successfully treated with bot-
ulinum toxin. DBS was offered when the positive effect of the in-
jections weakened, most probably due to an immune response 
against this substance. Patients with generalized dystonia were 
screened for a DYT1 mutation. Patients’ characteristics are sum-
marized in  table 1 . The last follow-up was performed in August 
2006.
 Neurosurgical Technique/Implants 
 Bilateral pallidal electrode implantation (model 3387; Med-
tronic, Minneapolis, Minn., USA) with intraoperative macroelec-
trode testing was either performed under propofol (12 patients) 
or local (6 patients) anesthesia with MRI-guided stereotaxy using 
a modified Leksell/Lerch system (Munich) or ventriculography 
combined with 3D stereotactic CT and MR imaging and a modi-
fied Riechert-Mundinger stereotactic head ring (Cologne).
 The methodology applied for imaging, treatment planning 
and implantation has been published in detail elsewhere  [11, 20] . 
The preliminary target within the GPi was defined as follows:
3 mm anterior to the AC-PC midpoint, 18–22 mm lateral to the 
midline and 3–6 mm below the IC plane  [21] . The standard target 
coordinates were adjusted based on individual anatomical land-
marks (third ventricle/optical tract). Intraoperative microelec-
trode recordings were not performed in this study. Permanent 
implantation of the stimulation system into a subcutaneous infra-
clavicular pouch (IPG, model, Soletra or Kinetra; Medtronic) was 
performed either after 3–5 days of testing for side effects with an 
external pulse generator system using percutaneous extensions 
(12 patients, Munich) or immediately after implantation of the 
Table 1. Characteristics of the study population
ID Age at
Surgery
years
Sex Duration
of disease1
years
DYT1
muta-
tion
Distribution
of dystonia
Follow-
up
months
1 45 f 4.3 no generalized 67.0
2 35 m 15.6 no generalized 70.0
3 23 f 19.9 no generalized 54.0
4 44 f 37.1 no generalized 51.0
5 24 f 18.0 no generalized 50.0
6 53 f 40.7 yes generalized 45.0
7 20 f 13.0 yes generalized 90.0
8 12 m 4.0 no generalized 68.0
9 14 f 2.0 yes generalized 59.0
10 61 m 19.0 no segmental 75.0
11 78 f 6.0 NA segmental 67.0
12 44 m 4.0 NA segmental 48.0
13 51 m 8.0 NA segmental 81.0
14 44 m 8.0 NA segmental 41.0
15 45 f 19.0 NA segmental 37.0
16 58 f 15.0 NA focal 73.0
17 70 f 31.0 NA focal 54.0
18 41 m 9.0 NA focal 50.0
ID = Patient identification number; NA = not assessed.
1 Preoperatively.
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deep brain electrodes (6 patients, Cologne). Prophylactic system-
ic antibiotic treatment (cefuroxime, 3  ! 1.5 g/day) was adminis-
tered to all patients perioperatively and for at least 1 week postop-
eratively. Hospitalization ranged from 14 to 24 days.
 Stimulation/Parameters 
 The most distal electrode contact of the quadripolar electrode 
which caused no side effects when activated was chosen for con-
tinuous monopolar stimulation with comparably high intensity 
from the beginning (mean 80   A). Thereafter, the amplitude was 
stepwise increased over several days to determine for each patient 
individually a level which gained maximum clinical response 
with no or minimal side effects (e.g. phosphenes, motor symp-
toms and speech disturbance). Stimulation parameters are sum-
marized in  table 2 .
 Patient Evaluation 
 Clinical outcome was assessed preoperatively, at discharge 
from hospital (mean 10 days after initial programming), and 3, 6 
and 12 months postoperatively and then annually) using the 
Burke-Fahn-Marsden (BFM) dystonia rating scale (motor and 
disability) for patients with generalized dystonia and the Tsui rat-
ing scale for patients with focal or segmental dystonia  [22, 23] . 
The Tsui score consists of several subscores assessing the ampli-
tude and duration of sustained movements, shoulder elevation 
and tremor. Due to its detailed subscores, we considered this score 
to be best suited to evaluate torticollis and segmental dystonia.
 Twelve patients received an immediate postoperative MRI to 
control electrode position. In 6 patients, the coordinates of the 
final electrode position were taken from intraoperative stereotac-
tic plain X-ray images. Finally, placement of the electrode (active 
contact) inside the GPi was verified using the individual custom-
ized planning software for co-registration with the treatment 
planning MRI (and the Schaltenbrand brain atlas  [24] ). The exact 
position of all active contacts was referenced to the AC-PC mid-
point (Matlab 7.1; MathWorks, Natick, Mass., USA).
 Statistical Methods 
 The Wilcoxon matched-pair signed-rank test was applied to 
compare changes in the rating scale scores pre- and postopera-
tively [response at discharge, 3 and 12 months, and long-term fol-
low-up ( 1 36 months)]. Student’s t test was used to analyze differ-
ences between population subgroups. A correlation analysis using 
the Spearman correlation coefficient along with linear regression 
analysis was used to test for pretreatment prognosticators of long-
term outcome (at 36 months) as well as correlation between elec-
trode localization and outcome. p  ! 0.05 was considered statisti-
cally significant. Statistical analyses were performed using the 
SPSS 14.0 and 16.0 software (SPSS, Chicago, Ill., USA).
 Results 
 Clinical Patient Outcome 
 In summary, most of our patients demonstrated a very 
rapid response to DBS with significant improvement in 
their symptoms already during the 1st postoperative 
week. Improvement was  1 50% in 4/9 patients with gen-
eralized and in 5/9 patients with focal/segmental dysto-
nia.  The follow-up of the entire patient group ranged 
from 37 to 90 months (mean 60 months).
 Generalized Dystonia. Patients with generalized dys-
tonia were severely affected with a high mean preopera-
tive BFM movement and disability score of 57 (median 
55, range 27–106) and 14.4 (median 14, range 7–26), re-
spectively. At discharge from hospital, there were mean 
improvements in the BFM movement score of 39.4% (me-
dian 38, range 0–68.8%) and in the BFM disability score 
of 29.9% (median 29, range 7.1–71.4%). After 3 months, 
both scores (movement and disability) further improved 
in 2 patients. In comparison to the immediate postopera-
tive status, the values remained stable in 5 individuals 
and had worsened in 2 patients. Intermediate analysis at 
12 months revealed mean improvements in the BMF 
movement and disability scores of 42.5 (median 63, range 
–16.0 to 81.3%) and 37.9% (median 30, range 7.1–73.3%). 
These improvements remained constant at the long-
term-follow up at 36 months and at the last follow-up in 
5, severely reduced in 2 and moderately reduced in 2 pa-
tients ( fig. 1 ,  2 ). The mean percent improvements in com-
parison to the preoperative status together with the sta-
tistical values are listed in  table 3 . Individual scores at 
follow-up are listed in  table 4 .
Table 2. Stimulation parameters (means 8 SD)
Amplitude, V Pulse width,   s Frequency, Hz
left right left right left right
Discharge 3.080.5 2.780.6 111.8831.7 111.8825.8 131.287.8 132.7813.7
3-month follow up 3.080.3 3.180.7 128.5839.2 128.8827.6 135.9814.2 136.2817.5
12-month follow-up 3.180.8 3.280.4 154.3846.9 147.9850.56 133.288.7 137.1816.3
36-month follow-up 3.280.8 3.480.6 144.3842.9 141.2841.9 134.3810.9 139.3817.9
Last follow-up (>36 months) 3.280.8 3.380.6 137.7843.8 134.1845.2 139.1815.8 140.6818.8
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 Focal/Segmental Dystonia (Cervical Dystonia). The 
overall mean reductions in the Tsui score were 36.8% 
(range 0–100%) at 3 months, 65.1% (range 16.7–100%) at 
12 months, 61.5% at 36 months (range 16.7–100%) and 
59.8% (range 16.7–100%) at the last follow-up. As shown 
in  figure 3 , outcome in patients displayed a large variabil-
ity, ranging from complete resolution of symptoms in 2 
cases with pure torticollis (patients 16 and 18) to only 
very moderate long-term improvement in another 3 pa-
tients (patients 12, 14 and 17). The mean percent im-
provements in comparison to the preoperative status to-
gether with the statistical values are listed in  table 5 . In-
dividual scores at follow-up are listed in  table 4 .
 Statistical Analysis. At the 3- and 12-month, and at the 
long-term follow-ups (36 months and  1 36 months, with a 
mean of 60 months), mean improvements were signifi-
cantly different compared with the preoperative status 
(Wilcoxon’s matched-pair signed-rank test) for both 
groups, i.e. general dystonia (motor and disability score, 
 table 3 ) and focal/segmental dystonia ( table 5 ). There was 
no statistically significant difference in the long-term ben-
efit between the 36-month and the last (‘open-label’ long-
term) follow-up. In generalized dystonia, correlation and 
linear regression analysis showed age at surgery (r 2 = 0.593, 
significance 0.004) and duration of disease prior to DBS
(r 2 = 0.712, significance 0.004) to be significant predictors 
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 Fig. 1, 2. Graph showing the course of BFM movement ( 1 ) and BFM disability scores ( 2 ) for the 9 patients with 
generalized dystonia in the long-term follow-up. The reference point was the date of electrode implantation. 
1 2
Table 3. BFM dystonia rating scale in generalized dystonia 
Preoperatively 3-month FU 12-month FU 36-month FU Last FU
BFM dystonia rating scale
Movement score 57.0825.6 36.0822.7 33.9824.0 27.6818.4 32.7827.3
Disability score 14.486.4 9.786.0 8.985.8 9.4822.0 10.488.1
Change to preoperatively
Movement
Change, % 36.8834.9 42.5837.2 50.3835.7 46.8836.5
p value 0.008 0.008 0.008 0.01
Disability
Change, % 35.6821.5 37.9826.4 32.9827.2 26.7837.7
p value 0.004 0.004 0.004 0.008
Means 8 SD. FU = Follow-up
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of long-term outcome at 36 months, e.g. patients with a 
disease duration prior to DBS  ! 15 years (4/9 patients) had 
a statistically significantly better long-term outcome (mean 
improvement in the BFM movement score of 73.6 vs. 
25.4%, p = 0.03, Student’s t test). For focal and segmental 
dystonia, no statistically significant correlation was found 
(factors tested: age at surgery, duration of disease prior to 
DBS, severity of symptoms and DYT-1 carrier status).
 Electrode Position. Postoperative MRI (12/18 patients) 
or stereotactic X-ray (6/18 patients) confirmed the correct 
Table 4. Individual outcome scores
ID Dystonia Assessment PO 1 week 3 months 12 months 36 months Last FU
1 generalized BFM-M 80 80 80 80 43 39 (67 months)
BFM-D 14 13 13 13 11 10
2 generalized BFM-M 27 12 8 7 6 5 (70 months)
BFM-D 7 5 3 4 4 4
3 generalized BFM-M 106 39 39 39 39 88 (54 months)
BFM-D 29 22 22 21 22 30
4 generalized BFM-M 43 33 53 50 45 45 (51 months)
BFM-D 9 7 6 8 10 13
5 generalized BFM-M 68 42 49 49 49 50 (50 months)
BFM-D 15 13 14 13 12 12
6 generalized BFM-M 37 35 35 36 36 38 (45 months)
BFM-D 10 6 6 7 8 9
7 generalized BFM-M 32 10 10 6 6 7 (90 months)
BFM-D 14 4 4 4 4 3
8 generalized BFM-M 55 35 25 19 10 10 (68 months)
BFM-D 17 12 9 6 7 7
9 generalized BFM-M 65 25 25 19 12 12 (59 months)
BFM-D 15 10 10 4 6 6
10 segmental Tsui 13 13 13 5 6 8 (75 months)
11 segmental Tsui 13 13 13 6 4 4 (67 months)
12 segmental Tsui 24 6 6 6 18 18 (48 months)
13 segmental Tsui 14 0 4 2 2 2 (81 months)
14 segmental Tsui 17 14 12 13 13 13 (41 months)
15 segmental Tsui 10 5 4 3 2 2 (37 months)
16 focal Tsui 10 2 1 0 0 0 (73 months)
17 focal Tsui 12 12 11 10 10 10 (54 months)
18 focal Tsui 6 2 0 0 0 0 (50 months)
Individual outcome scores applying either the BFM score in generalized dystonia or the Tsui-score in focal/segmental dystonia.
The 36-month follow-up was performed within a range of 32–40 months. ID = Patient identification number; PO = preoperative-
ly; FU = follow-up; BFM-M = BFM movement; BFM-D = BFM disability.
Table 5. Tsui rating scale in patients with focal and segmental dystonia 
Preoperatively 3-month FU 12-month FU 36-month FU Last FU
(>36 months)
Tsui score 13.285.1  5.285.2  5.084.4  6.186.3  6.386.3
Change to preoperatively
Change, % 36.8839.4 65.1830.0 61.5833.1 59.8834.0
p value 0.01 0.003 0.003 0.003
Means 8 SD. FU = Follow-up.
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placement of the electrodes within the (posteroventral) 
GPi. Mean stereotactic coordinates of the active electrode 
contacts were: (1) left hemisphere: 3.91 mm (range 0.0–7.2 
mm) anterior to the midcommisural point, 20.4 mm 
(range 14.6–25.2 mm) lateral to the midline of the 3rd 
ventricle and 1.7 mm (range 0–9.1 mm) below the AC-PC 
plane, and (2) right hemisphere: 4.2 mm (range 0.0–7.4 
mm) anterior to the midcommisural point, 21.0 mm 
(range 17.6–26.0 mm) lateral to the midline of the 3rd 
ventricle and 1.8 mm (range 0–9.1 mm) below the AC-PC 
plane.
 The 3 patients with the most anteriorly positioned 
electrodes had no (patients 4 and 6) or only moderate (pa-
tient 5) long-term success. There was neither a statisti-
cally significant correlation between electrode position 
and outcome in patients with extremely worse or better 
outcome nor in the subgroups with an outcome  ! or
 1 50% ( fig. 4 ).
 Stimulation Parameters 
 Parameters at discharge and at follow-up are given in 
 table 2 . The initial amplitude settings (on discharge) had 
to be increased in all patients during follow-up in order 
to further optimize the control of involuntary move-
ments.
 Pulse Generator Replacement. The mean interval for 
replacement was 43.4 (17 patients, range 31–59 months) 
and 38.3 months (5 patients, range 32–48 months) for the 
first and second replacement, respectively. There was no 
statistically significant difference in time to replacement 
between the different types of IPG (Itrel II, Soletra or Ki-
netra).
 Complications 
 Perioperative Mortality and Morbidity. Despite 1 case 
with a subcutaneous hematoma at the site of the exten-
sion cable (complete recovery without permanent defi-
cits), there was no other directly surgery-related morbid-
ity or mortality in this patient series.
 Infections.  Local infections were encountered in 2 pa-
tients: One patient (patient 7) presented with local infec-
tion at the burr hole necessitating removal of the left DBS 
electrode 14 days after the primary procedure. Re-im-
plantation was performed 3 months later without compli-
cations, and the same excellent stimulation result as be-
fore was achieved. Another patient (patient 13) suffered 
from a local infection at the right infraclavicular IPG 6 
weeks after IPG replacement in an outside institution (46 
months after primary implantation) requiring IPG ex-
plantation. Re-implantation was performed 6 weeks later 
without further sequelae.
 Long-Term Complications/Side Effects. One young fe-
male patient suffering from generalized dystonia (patient 
9) with an excellent clinical course and initially signifi-
cant improvement due to GPi-DBS developed (with a de-
lay of 3 years) extreme psychosocial behavioral abnor-
malities (aggressiveness/uncooperativeness) necessitat-
ing intensive psychological treatment. With adequate 
psychological support, her clinical status stabilized. De-
pending on stimulation intensity, mild speech distur-
bances occurred in 2 patients. Due to the otherwise excel-
lent clinical response, this mild impairment was well ac-
cepted. An accidental inactivation of the IPGs (i.e. an 
airport metal detector and a professional kitchen ma-
chine) with almost immediate re-occurrence of dystonic 
symptoms was observed in 2 patients.
 Hardware Complications. In 1 patient (patient 9), we 
documented loosening of the burr hole cap with consec-
utive electrode dislocation (39 months postoperatively) 
and in the later course (58 months postoperatively) break-
age of the extension cable. Both events were accompanied 
by a loss of stimulation and consecutive severe worsening 
of clinical symptoms. Complete restitution could be 
achieved in either event by immediate operative revision 
(i.e. revision of the DBS electrode and the extension cable, 
respectively).
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 Discussion 
 High-frequency DBS with neuromodulatory instead 
of destructive effects, hence being reversibly and indi-
vidually adjustable, and with its high therapeutic efficacy 
has replaced ablative procedures like pallidotomy or thal-
amotomy during the last 10 years. This development was 
paralleled by an increasing acceptance of stereotactic 
neurosurgery for the treatment of movement disor-
ders. [8–15, 25] . Moreover, prospective multicenter trials 
with a controlled (randomized) protocol proved the ef-
ficacy of DBS for patients with generalized dystonia  [16–
18] .
 The present analysis addressing postoperative and 
long-term (mean follow-up: 60 months) clinical results in 
a cohort of 18 patients covered different types of primary 
dystonia, including the largest long-term series of pa-
tients suffering from focal/segmental dystonia to date. 
Clinical symptoms improved in both patient groups sig-
nificantly. In detail, at the 36-month and at the last fol-
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low-up examination (36–90 months), the average clinical 
benefit expressed as a reduction in the BMF movement 
and disability scores were 50/33 and 47/27%, respectively, 
in the group with generalized dystonia and 62 and 60% 
in patients with focal/segmental dystonia who were as-
sessed using the Tsui scale.
 In contrast to most previous reports, in the present 
study, we documented for a reasonably high number of 
patients (9/18) a significant improvement in symptoms 
(improvement  1 50%) already during the 1st postopera-
tive week  [10, 14–16] . In agreement with Kupsch et al.  [18] , 
these early beneficial effects became visible in mobile 
dystonia rather than in fixed dystonic postures. However, 
this is observation cannot be generalized since there was 
no statistically sound proof. For reasons of clinical prac-
ticability, we applied two different score systems compli-
cating the direct comparison of patients with general dys-
tonia and those with predominant torticollis in the seg-
mental/focal group. In the latter cohort, the Tsui score, a 
scoring system for torticollis widely used by European 
groups, had been applied, since features of focal/segmen-
tal dystonia are assessed in more detail  [23] . As a conse-
quence, particular aspects of the results will be discussed 
individually for both patient cohorts.
 Generalized Dystonia 
 The present analysis showed that the significant im-
provements in BFM scores 12 months after the start of 
DBS (movement: 46.8  8 36.5% and disability: 26.7  8 
37.7%) were maintained during the long-term follow-up 
(maximum follow-up time: 72 months, mean follow-up 
time: 59.6 months) in 5/9 patients, with a mean motor 
improvement of 50.3% at the 36-month follow-up and ex-
cellent results in 3 young patients (age at surgery 12, 13 
and 20 years), with an improvement of 81, 82 and 82%, 
respectively. These results compare very well to the pro-
spective short- and long-term outcome reported by Vid-
ailhet et al.  [16, 17] who also found improvements  1 75% 
in (only) one third of their patients. However, in 3 pa-
tients with significant initial benefit, we registered mod-
erate (patients 4–6) and in 1 patient (patient 3) substantial 
worsening in the positive stimulation effect over time 
( fig. 1 ,  2 ;  table 3 ,  4 ). In this group of patients with a his-
tory of dystonia prior to treatment of  1 15 years, long-
term outcome was found to be statistically significantly 
worse than in individuals with a shorter history of dysto-
nia (mean improvement in the BFM movement score 25.4 
vs. 73.6%, p = 0.03). Moreover, in contrast to other stud-
ies, correlation and linear regression analysis revealed 
age at surgery and duration of disease prior DBS to be 
statistically significant predictors for long-term outcome 
(at 36 months) in our series  [18] . In concordance to the 
results of the randomized controlled series by Kupsch et 
al.  [18] , there was also no statistical difference in outcome 
between the patients with or without DYTI mutation in 
our patient cohort.
 These observations might indicate the necessity of 
early neurosurgical intervention to achieve an optimal 
clinical outcome. Although the results have to be con-
firmed in a prospective study, early treatment seems to be 
even more important in pediatric/juvenile patients to 
prevent irreversible impairment of motor function (mus-
cle, joint and bone destruction/deformity).
 Further studies in patients with insufficient or de-
creasing response have to elucidate the benefit of low-fre-
quency stimulation (60 Hz), yielding significant improve-
ment in 89% after 12 months in a study by Alterman et 
al.  [26] , or targeting of the nucleus subthalmicus, an al-
ternative approach with very promising results  [27, 28] . 
However, both concepts seem very interesting (with obvi-
ous advantages: e.g. a longer battery life) and might be 
applied in our institution in the future, especially in pa-
tients with inappropriate response to ‘standard’ high-fre-
quency Gpi-DBS.
 Electrode Position 
 Despite the fact that the 3 patients with the most ante-
riorly positioned electrodes had no (patients 4 and 6) or 
only moderate (patient 5) long-term improvement (gen-
eralized dystonia), there was neither a statistically sig-
nificant correlation in electrode position and outcome in 
patients with extremely worse or better outcome nor in 
the subgroups with an outcome  ! or  1 50% ( fig. 4 ). In gen-
eral, position of the active contacts within the GPi was in 
agreement with previously published results  [13] .
 Segmental/Focal Dystonia 
 In accordance with other studies, outcome in patients 
with segmental/focal dystonia varied largely during long-
term follow-up, which is reflected by the great standard 
deviation in documented scores (6.3 at the last follow-up) 
 [8, 14] . There was neither a significantly higher degree of 
fixed posture in the patients with a less favorable response 
(as documented by the Tsui subscores, data not shown) 
nor could statistically significant predictors for outcome 
be detected. The best effect was observed for cervical dys-
tonic symptoms (2 patients with pure torticollis showed 
a stable complete relief of their symptoms) as well as for 
the Meige syndrome. In our series, results were compa-
rably worse in patients with dystonic movements in the 
 Mehrkens /Bötzel /Steude /Zeitler /
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shoulder/arm region and/or in patients with predominat-
ing clonic-dystonic symptoms (e.g. dystonic tremor). 
 However, bearing in mind that other groups applied volt-
ages as high as 5.0 V, generally stating that GPi-DBS is less 
effective in ‘complex’ segmental dystonia may be mis-
leading, since the voltages used in our patients ( ! 3.6 V) 
may have been too low to observe a significant benefit  [19, 
29] . Despite these limitations, the overall improvement 
remained stable if referred to the total follow-up time 
(maximum 81 months) and was statistically significant 
compared with baseline values.
 These results support the important role of GPi-DBS 
in patients with cervical dystonia, confirming previous 
data in patients with a significantly shorter follow-up  [18, 
29–31] .
 Complications 
 In contrast to other reports covering a number of pa-
tients comparable to our series, stereotactic implantation 
of the brain electrodes did not give rise to mortality or 
severe morbidity (e.g. symptomatic intracerebral hemor-
rhage or new neurological sequelae)  [32] . Also, the rate of 
other perioperative adverse events was low (1/18 patients, 
6%) in our patients. The comparably high number of pa-
tients (4/18 patients, 22.2%) who presented with implant-
related (long-term) complications (local infections, elec-
trode dislocation or peripheral cable breakage) is in ac-
cordance with previously published reports addressing 
this particular problem  [18, 33] . Of note, the two infec-
tions encountered were not long-term complications. In 
the patient requiring electrode explantation, the local in-
fection at the burr hole occurred 14 days after implanta-
tion and after 10 days of externalization of the electrodes. 
In the patient with IPG infection, infection manifested at 
the long-term follow-up (46 months after initial surgery); 
however, the patient had undergone IPG replacement 
only 6 weeks prior to manifestation of the infection.
 With the exception of temporary aggressive behavior 
documented in a young female suffering from general-
ized dystonia, who responded very well to adequate psy-
chological treatment, other mood disturbances were not 
observed (e.g. a tendency to depressive or even suicidal 
behavior), being in contrast to others  [34] .
 The mild speech disturbances (dysarthria) noted in 2 
cases were not clinically significant and were well toler-
ated, because of the excellent clinical improvement in 
their dystonic symptoms.
 Conclusion 
 GPi-DBS is safe in patients suffering from primary 
generalized, segmental or focal dystonia with excellent 
short-term stimulation effects as already published. In 
the present analysis, long-term results were also excellent 
in 3 young patients with generalized dystonia and 2 pa-
tients with torticollis. Patients with segmental dystonia 
showed marked but incomplete relief of their symptoms. 
Early treatment seems to be crucial to achieve optimal 
therapeutic benefit in patients with generalized dysto-
nia.
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